推进人体血吸虫病疫苗的发展。
Advancing the Development of a Human Schistosomiasis Vaccine.
机构信息
Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; James A. Baker III Institute of Public Policy, Rice University, Houston, TX, USA.
Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA.
出版信息
Trends Parasitol. 2019 Feb;35(2):104-108. doi: 10.1016/j.pt.2018.10.005. Epub 2018 Nov 16.
Three vaccines against human schistosomiasis are in different phases of clinical development, and a fourth is expected to enter the clinic soon. Successful introduction of an efficacious preventive human schistosomiasis vaccine will require integration into existing health systems such as those that deliver childhood vaccines or mass drug administration programs.
三种抗人体血吸虫病疫苗处于不同的临床开发阶段，预计第四种疫苗很快将进入临床阶段。成功推出一种有效的预防性人体血吸虫病疫苗，将需要将其纳入现有的卫生系统，如那些提供儿童疫苗或大规模药物管理方案的系统。
Zotero 插件